Galway firm plans to double €3m funding

The funding would secure Crospon’s cashflow position, enabling it to launch its patented Endoflip product on the market

10th January, 2009

Galway firm Crospon plans to double the e 3 million funding amount it raised last April, in a new funding round planned for this year.

Crospon chief executive John O’Dea said the funding would secure its cashflow position, enabling it to launch its patented Endoflip product on the market.

The company has spent the past year fine-tuning Endoflip, a diagnostic tool for patients with gastroesophageal reflux disease (Gerd), for regulatory approval.

Subscribe from just €1 for the first month!


What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

The year in review

Legacy Richie Oakley 1 year ago

Newsround: What Thursday’s papers say

Legacy Leanna Byrne 6 years ago

More cycle routes, expansion of Luas to Bray and new bus network proposed

Legacy Digital Desk 6 years ago